Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07400718Not ApplicableCompleted

Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators

Role: lead

NCT06623799Recruiting

Impact of Help-Seeking Behaviors on Allergic Rhinitis and Mental Health: A Longitudinal Study

Role: lead

NCT06603935Not ApplicableEnrolling By Invitation

Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)

Role: lead

All 3 trials loaded